Literature DB >> 22067007

A divergent and selective synthesis of isomeric benzoxazoles from a single N-Cl imine.

Cheng-yi Chen1, Teresa Andreani, Hongmei Li.   

Abstract

A divergent and regioselective synthesis of either 3-substituted benzisoxazoles or 2-substituted benzoxazoles from readily accessible ortho-hydroxyaryl N-H ketimines is described. The reaction proceeds in two distinct pathways through a common N-Cl imine intermediate: (a) N-O bond formation to form benzisoxazole under anhydrous conditions and (b) NaOCl mediated Beckmann-type rearrangement to form benzoxazole, respectively. The reaction path also depends on the electronic nature of the aromatic ring, with the electron-rich aromatic rings favoring the rearrangement and the electron-deficient rings favoring the N-O bond formation. A Beckmann-type rearrangement mechanism via net [1,2]-aryl migration for the formation of 2-substituted benzoxazole is proposed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067007     DOI: 10.1021/ol202844c

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Enantioselective Crossed Photocycloadditions of Styrenic Olefins by Lewis Acid Catalyzed Triplet Sensitization.

Authors:  Zachary D Miller; Byung Joo Lee; Tehshik P Yoon
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-30       Impact factor: 15.336

2.  One-step synthesis of azole- and benzazole-based sulfonamides in aqueous media.

Authors:  Hassan Zali-Boeini; Zhaleh Najafi; Bahareh Abtahi; Hajar Golshadi Ghaleshahi
Journal:  Mol Divers       Date:  2015-01-23       Impact factor: 2.943

3.  Synthesis of o-(dimethylamino)aryl ketones, acridones, acridinium salts, and 1H-indazoles by the reaction of hydrazones and arynes.

Authors:  Anton V Dubrovskiy; Richard C Larock
Journal:  J Org Chem       Date:  2012-12-03       Impact factor: 4.354

4.  Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease.

Authors:  Julien Lalut; Hugo Payan; Audrey Davis; Cédric Lecoutey; Rémi Legay; Jana Sopkova-de Oliveira Santos; Sylvie Claeysen; Patrick Dallemagne; Christophe Rochais
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.